Other Virus Citation List:
June 24, 2009 – July 7, 2009
HEPATITIS C VIRUS
1. Discovery
of novel P3 sulfonamide-capped inhibitors of HCV NS3 protease. Inhibitors with
improved cellular potencies.
Venkatraman S, Blackman M, Wu W, Nair L, Arasappan A, Padilla A, Bogen S,
Bennett F, Chen K, Pichardo J, Tong X, Prongay A, Cheng KC, Girijavallabhan V,
George Njoroge F.
Bioorg Med Chem. 2009 Jul 1;17(13):4486-95. Epub
2009 May 9.
PMID: 19481946 [PubMed - in process]
2. Discovery
of novel phosphonate derivatives as hepatitis C virus NS3 protease inhibitors.
Sheng XC, Pyun HJ, Chaudhary K, Wang J, Doerffler E, Fleury M, McMurtrie D,
Chen X, Delaney WE 4th, Kim CU.
Bioorg Med Chem Lett. 2009 Jul 1;19(13):3453-7.
Epub 2009 May 9.
PMID: 19477126 [PubMed - in process]
3. Antiviral
effect of ribonuclease conjugated oligodeoxynucleotides targeting the IRES RNA
of the hepatitis C virus.
Gamble C, Trotard M, Le Seyec J, Abreu-Guerniou V, Gernigon N, Berrée F,
Carboni B, Felden B, Gillet R.
Bioorg Med Chem Lett. 2009 Jul 1;19(13):3581-5.
Epub 2009 May 4.
PMID: 19450979 [PubMed - in process]
ISI Web of Science citations:
4. Wang, SY. et al.
Bioactivity-guided
screening identifies pheophytin a as a potent anti-hepatitis C virus compound
from Lonicera hypoglauca Miq.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 2009 (July) 385: 230 - 235